Close Menu

NEW YORK (GenomeWeb) – BioGx announced it has received CE-IVD marking for a real-time PCR-based test to detect Influenza A, Influenza B, and respiratory syncytial virus.

The assay uses samples from nasopharyngeal swabs and runs on the Becton Dickinson BD Max system. Offered as a single tube that snaps into the BD Max RNA/DNA extraction cartridge, the test increases lab efficiency, the firm said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.